Organ-on-a-chip Organoid
Highlighted and sponsored news.

Why the FDA’s Plan to Embrace Human-Specific Research is Cause for Optimism

By Ross Dobie. In this article, I digest the recent announcement and outline the key reasons for my optimism regarding the proposed roadmap. My thoughts / insights are marked in italics.
Go to the profile of WORC Update
WORC Update and Pelin Saglam-Metiner
2 contributors
Why the FDA’s Plan to Embrace Human-Specific Research is Cause for Optimism
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

Share with...

...or copy the link

This is a representation of how your post may appear on social media. The actual post will vary between social networks

The tide is turning as the U.S. Food and Drug Administration (FDA) gives the strongest signal to date that the future of preclinical safety assessment in the U.S. will rely increasingly on human-specific research as animal testing is phased out. Their mission is clear: ‘to improve drug safety and accelerate the evaluation process, while reducing animal experimentation, lowering research and development (R&D) costs, and ultimately, drug prices.’

READ HERE

Go to the profile of WORC Update

Contributors

Author

Go to the profile of WORC Update

WORC Update (He/Him)

Head of community, WORC.Community (A Caterpillar Hill Limited venture).

Contributing author

Go to the profile of Pelin Saglam-Metiner

Pelin Saglam-Metiner (She/Her)

Bioengineer, Ege University Bioengineering Department

Multiple Contributors
WORC Update and Pelin Saglam-Metiner

Contributors

Author

Go to the profile of WORC Update

WORC Update (He/Him)

Head of community, WORC.Community (A Caterpillar Hill Limited venture).

Contributing author

Go to the profile of Pelin Saglam-Metiner

Pelin Saglam-Metiner (She/Her)

Bioengineer, Ege University Bioengineering Department

Please sign in or register for FREE

If you are a registered user on WORC.Community, please sign in

Sign In Register

Recommended Content

Cookies

We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.

You can consent to the use of such technologies by closing this notice.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.